These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36613510)

  • 1. Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches.
    Vale N; Pereira M; Santos J; Moura C; Marques L; Duarte D
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Interaction of CPP2 Coupled with Thiazole Derivates Combined with Clotrimazole and Antineoplastic Drugs in Prostate and Colon Cancer Cell Lines.
    Duarte D; Vale N
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs.
    Duarte D; Cardoso A; Vale N
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
    Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
    Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells.
    Abaza MS; Bahman AM; Al-Attiyah RJ
    World J Gastroenterol; 2008 Sep; 14(33):5162-75. PubMed ID: 18777593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.
    Duarte D; Nunes M; Ricardo S; Vale N
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
    Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
    Sen K; Banerjee S; Mandal M
    Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anti-transferrin receptor antibody enhanced the growth inhibitory effects of chemotherapeutic drugs on human non-hematopoietic tumor cells.
    Shen X; Zhu HF; He FR; Xing W; Li L; Liu J; Yang J; Pan XF; Lei P; Wang ZH; Shen GX
    Int Immunopharmacol; 2008 Dec; 8(13-14):1813-20. PubMed ID: 18817895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer.
    Ma Y; Liu D; Wang D; Wang Y; Fu Q; Fallon JK; Yang X; He Z; Liu F
    Mol Pharm; 2014 Aug; 11(8):2623-30. PubMed ID: 24712391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
    Fioravanti A; Canu B; Alì G; Orlandi P; Allegrini G; Di Desidero T; Emmenegger U; Fontanini G; Danesi R; Del Tacca M; Falcone A; Bocci G
    Eur J Pharmacol; 2009 Oct; 619(1-3):8-14. PubMed ID: 19695243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy of the taxanes and antimetabolites: its use and limitations.
    Smorenburg CH; Sparreboom A; Bontenbal M; Verweij J
    Eur J Cancer; 2001 Dec; 37(18):2310-23. PubMed ID: 11720823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of paclitaxel and 5-fluorouracil in multicellular layers of human colorectal cancer cells.
    Choi MS; Kim SH; Kuh HJ
    Oncol Rep; 2011 Mar; 25(3):863-70. PubMed ID: 21225235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ratiometric co-encapsulation and co-delivery of doxorubicin and paclitaxel by tumor-targeted lipodisks for combination therapy of breast cancer.
    Feng C; Zhang H; Chen J; Wang S; Xin Y; Qu Y; Zhang Q; Ji W; Yamashita F; Rui M; Xu X
    Int J Pharm; 2019 Apr; 560():191-204. PubMed ID: 30769131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid peptides as platform for synchronized combination therapy.
    Ashrafichoobdar E; Perez T; Ayalew L; Gorbanwand V; Monroy J; Slowinska K
    Colloids Surf B Biointerfaces; 2023 Jun; 226():113326. PubMed ID: 37116378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms.
    Alsherbiny MA; Bhuyan DJ; Low MN; Chang D; Li CG
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic anti-tumor activity through combinational intratumoral injection of an in-situ injectable drug depot.
    Kim DY; Kwon DY; Kwon JS; Park JH; Park SH; Oh HJ; Kim JH; Min BH; Park K; Kim MS
    Biomaterials; 2016 Apr; 85():232-45. PubMed ID: 26874285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio.
    Baabur-Cohen H; Vossen LI; Krüger HR; Eldar-Boock A; Yeini E; Landa-Rouben N; Tiram G; Wedepohl S; Markovsky E; Leor J; Calderón M; Satchi-Fainaro R
    J Control Release; 2017 Jul; 257():118-131. PubMed ID: 27374630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Honeybee Venom Synergistically Enhances the Cytotoxic Effect of CNS Drugs in HT-29 Colon and MCF-7 Breast Cancer Cell Lines.
    Duarte D; Falcão SI; El Mehdi I; Vilas-Boas M; Vale N
    Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.